Ciro R. Rinaldi

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 185 citations

Medicine, Hematology, Pharmacology +9

The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double‐blind, double‐dummy, symptom study (RELIEF)

Ruben A. Mesa, Alessandro M. Vannucchi, Abdulraheem Yacoub et al. · British Journal of Haematology · 2016 · 88 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

EVI1 Impairs Myelopoiesis by Deregulation of PU.1 Function

Leopoldo Laricchia‐Robbio, Kavitha Premanand, Ciro R. Rinaldi et al. · Cancer Research · 2009 · 73 citations · Full text

Life Sciences, Hematology, Molecular Biology +15

Repression of RUNX1 Activity by EVI1: A New Role of EVI1 in Leukemogenesis

Vitalyi Senyuk, Kislay K. Sinha, Donglan Li et al. · Cancer Research · 2007 · 66 citations

Life Sciences, Genetics, Molecular Biology +15

Point Mutations in Two EVI1 Zn Fingers Abolish EVI1-GATA1 Interaction and Allow Erythroid Differentiation of Murine Bone Marrow Cells

Leopoldo Laricchia‐Robbio, Raffaella Fazzina, Donglan Li et al. · Molecular and Cellular Biology · 2006 · 66 citations · Full text

Life Sciences, Genetics, Hematology +15